Effect of high-pressure homogenization and stabilizers on the physicochemical properties of curcumin-loaded glycerol monooleate/chitosan nanostructures

Nanomedicine

Volumn 7, Issue 12, 2012, Pages 1863-1876

  Mistry, Pinal H ^a   Mohapatra, Sarat K ^a   Dash, Alekha K ^a  

^a CREIGHTON UNIVERSITY   (United States)

Author keywords

Caco 2 cells; chitosan; curcumin; glyceryl monooleate; high pressure homogenization; poloxamer 407; polyvinyl alcohol

Indexed keywords

CHITOSAN; CURCUMIN; GLYCEROL OLEATE; NANOMATERIAL; POLOXAMER; POLYVINYL ALCOHOL; STABILIZING AGENT;

ARTICLE; CHEMICAL PROCEDURES; CONTROLLED STUDY; DRUG FORMULATION; DRUG RELEASE; DRUG STABILITY; HIGH PRESSURE HOMOGENIZATION; IN VITRO STUDY; MOISTURE; NANOEMULSION; PARTICLE SIZE; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; ULTRASOUND; ZETA POTENTIAL;

ANTINEOPLASTIC AGENTS; CACO-2 CELLS; CHITOSAN; CURCUMIN; DRUG CARRIERS; EXCIPIENTS; GLYCERIDES; HUMANS; NANOSTRUCTURES; POLOXAMER; POLYVINYL ALCOHOL; PRESSURE;

EID: 84871306094     PISSN: 17435889     EISSN: 17486963     Source Type: Journal    
DOI: 10.2217/nnm.12.49     Document Type: Article

References (49)

1. Anand P, Thomas SG, Kunnumakkara AB et al. Biological activities of curcumin and its analogues (congeners) made by man and Mother Nature. Biochem. Pharmacol. 76(11), 1590-1611 (2008).
2. Karunagaran D, Rashmi R, Kumar TR. Induction of apoptosis by curcumin and its implications for cancer therapy. Curr. Cancer Drug Targets 5(2), 117-129 (2005).
3. Reuter S, Eifes S, Dicato M, Aggarwal BB, Diederich M. Modulation of anti-apoptotic and survival pathways by curcumin as a strategy to induce apoptosis in cancer cells. Biochem. Pharmacol. 76(11), 1340-1351 (2008).
4. Ireson CR, Jones DJ, Orr S et al. Metabolism of the cancer chemopreventive agent curcumin in human and rat intestine. Cancer Epidemiol. Biomarkers Prev. 11(1), 105-111 (2002).
5. Anand P, Kunnumakkara AB, Newman RA et al. Bioavailability of curcumin: problems and promises. Mol. Pharm. 4(6), 807-818 (2007).
6. Price LC, Vuescher RW. Decomposition of turmeric curcuminoids as affected by light, solvent and oxygen. J. Food Biochem. 20(5), 125-133 (1996).
7. Wang YJ, Pan MH, Cheng AL et al. Stability of curcumin in buffer solutions and characterization of its degradation products. J. Pharm. Biomed. Anal. 15(12), 1867-1876 (1997).
8. Bisht S, Feldmann G, Soni S et al. Polymeric nanoparticle-encapsulated curcumin ('nanocurcumin'): a novel strategy for human cancer therapy. J. Nanobiotechnol. 5, 3 (2007).
9. Duan J, Zhang Y, Han S et al. Synthesis and in vitro/in vivo anti-cancer evaluation of curcumin-loaded chitosan/poly(butyl cyanoacrylate) nanoparticles. Int. J. Pharm. 400(1-2), 211-220 (2010).
10. Li L, Braiteh FS, Kurzrock R. Liposome-encapsulated curcumin: in vitro and in vivo effects on proliferation, apoptosis, signaling, and angiogenesis. Cancer 104(6), 1322-1331 (2005).
11. Tonnesen HH, Masson M, Loftsson T. Studies of curcumin and curcuminoids. XXVII. Cyclodextrin complexation: solubility, chemical and photochemical stability. Int. J. Pharm. 244(1-2), 127-135 (2002).
12. Paradkar A, Ambike AA, Jadhav BK, Mahadik KR. Characterization of curcumin-PVP solid dispersion obtained by spray drying. Int. J. Pharm. 271(1-2), 281-286 (2004).
13. Mehnert W, Mader K. Solid lipid nanoparticles: production, characterization and applications. Adv. Drug Deliv. Rev. 47(2-3), 165-196 (2001).
14. Abuchowski A, van Es T, Palczuk NC, Davis FF. Alteration of immunological properties of bovine serum albumin by covalent attachment of polyethylene glycol. J. Biol. Chem. 252(11), 3578-3581 (1977).
15. Garcia-Fuentes M, Prego C, Torres D, Alonso MJ. A comparative study of the potential of solid triglyceride nanostructures coated with chitosan or poly(ethylene glycol) as carriers for oral calcitonin delivery. Eur. J. Pharm. Sci. 25(1), 133-143 (2005).
16. Verma S, Kumar S, Gokhale R, Burgess DJ. Physical stability of nanosuspensions: investigation of the role of stabilizers on Ostwald ripening. Int. J. Pharm. 406(1-2), 145-152 (2011).
17. Trickler WJ, Nagvekar AA, Dash AK. A novel nanoparticle formulation for sustained paclitaxel delivery. AAPS Pharm. Sci. Tech. 9(2), 486-493 (2008).
18. Trickler WJ, Nagvekar AA, Dash AK. The in vitro sub-cellular localization and in vivo efficacy of novel chitosan/GMO nanostructures containing paclitaxel. Pharm. Res. 26(8), 1963-1973 (2009).
19. Trickler WJ, Khurana J, Nagvekar AA, Dash AK. Chitosan and glyceryl monooleate nanostructures containing gemcitabine: potential delivery system for pancreatic cancer treatment. AAPS Pharm. Sci. Tech. 11(1), 392-401 (2010).
20. Trickler WJ, Munt DJ, Jain N, Joshi SS, Dash AK. Antitumor efficacy, tumor distribution and blood pharmacokinetics of chitosan/glyceryl-monooleate nanostructures containing paclitaxel. Nanomedicine (Lond). 6(3), 437-448 (2011).
21. Lacasse FX, Filion MC, Phillips NC, Escher E, McMullen JN, Hildgen P. Influence of surface properties at biodegradable microsphere surfaces: effects on plasma protein adsorption and phagocytosis. Pharm. Res. 15(2), 312-317 (1998).
22. Pandit AA, Dash AK. Surface modified solid lipid nanoparticulate formulation for ifosfamide: development and characterization. Nanomedicine (Lond.) 6(8), 1397-1412 (2011).
23. Dumortier G, Grossiord JL, Agnely F, Chaumeil JC. A review of poloxamer 407 pharmaceutical and pharmacological characteristics. Pharm. Res. 23(12), 2709-2728 (2006).
24. Dinda A, Biswal I, Das D et al. Effect of stabilizers and process parameters for budesonide loaded PLGA-nanoparticles. Int. J. Drug Deliv. 3(2), 371-380 (2011).
25. Pan R, Qiang S, Liew K, Zhao Y, Wang R, Zhu J. Effect of stabilizer on synthesis of indium tin oxide nanoparticles. Powder Technol. 189(1), 126-129 (2009).
26. Vandervoort J, Yoncheva K, Ludwig A. Influence of the homogenisation procedure on the physicochemical properties of PLGA nanoparticles. Chem. Pharm. Bull. (Tokyo) 52(11), 1273-1279 (2004).
27. Uner M, Yener G. Importance of solid lipid nanoparticles (SLN) in various administration routes and future perspectives. Int. J. Nanomed. 2(3), 289-300 (2007).
28. Floury J, Desrumaux A, Lardières J. Effect of high-pressure homogenization on droplet size distributions and rheological properties of model oil-in-water emulsions. Innovat. Food Sci. Emerg. Technol. 1(2), 127-134 (2000).
29. Müller RH, Peters K. Nanosuspensions for the formulation of poorly soluble drugs: I. Preparation by a size-reduction technique. Int. J. Pharm. 160(2), 229-237 (1998).
30. Dong Y, Feng S. Poly(d,l-lactide-co-glycolide) (PLGA) nanoparticles prepared by high pressure homogenization for paclitaxel chemotherapy. Int. J. Pharm. 342(1-2), 208-214 (2007).
31. Donsi F, Wang Y, Li J, Huang Q. Preparation of curcumin sub-micrometer dispersions by high-pressure homogenization. J. Agric. Food Chem. 58(5), 2848-2853 (2010).
32. Gao Y, Li Z, Sun M et al. Preparation and characterization of intravenously injectable curcumin nanosuspension. Drug Deliv. 18(2), 131-142 (2011).
33. Ravichandran R. Preparation and characterization of curcumin nanosuspension for enhanced solubility and dissolution velocity. Int. J. Nano Biomater. 3(2), 153 (2010).
34. Cheng J, Weijun K, Yun L et al. Development and validation of UPLC method for quality control of Curcuma longa Linn.: fast simultaneous quantitation of three curcuminoids. J. Pharm. Biomed. Anal. 53(1), 43-49 (2010).
35. Mu L, Feng SS. Vitamin E TPGS used as emulsifier in the solvent evaporation/extraction technique for fabrication of polymeric nanospheres for controlled release of paclitaxel (Taxol®). J. Control. Rel. 80(1-3), 129-144 (2002).
36. Chen X, Young TJ, Sarkari M, Williams RO 3rd, Johnston KP. Preparation of cyclosporine A nanoparticles by evaporative precipitation into aqueous solution. Int. J. Pharm. 242(1-2), 3-14 (2002).
37. Qian C, McClements DJ. Formation of nanoemulsions stabilized by model food-grade emulsifiers using high-pressure homogenization: factors affecting particle size. Food Hydrocoll. 25(5), 1000-1008 (2011).
38. Tamilvanan S, Kumar BA, Senthilkumar SR, Baskar R, Sekharan TR. Stability assessment of injectable castor oil-based nano-sized emulsion containing cationic droplets stabilized by poloxamer-chitosan emulsifier films. AAPS Pharm. Sci. Tech. 11(2), 904-909 (2010).
39. Illum L, Jacobsen LO, Muller RH, Mak E, Davis SS. Surface characteristics and the interaction of colloidal particles with mouse peritoneal macrophages. Biomaterials 8(2), 113-117 (1987).
40. Kishida A, Dressman JB, Yoshioka S, Aso Y, Takeda Y. Some determinants of morphology and release rate from poly(l)lactic acid microspheres. J. Control. Rel. 13(1), 83-89 (1990).
41. Sun L, Zhou S, Wang W, Li X, Wang J, Weng J. Preparation and characterization of porous biodegradable microspheres used for controlled protein delivery. Colloids Surf. A 345(1-3), 173-181 (2009).
42. Lee SH, Heng D, Ng WK, Chan HK, Tan RB. Nano spray drying: a novel method for preparing protein nanoparticles for protein therapy. Int. J. Pharm. 403(1-2), 192-200 (2011).
43. Miyazaki Y, Onuki Y, Yakou S, Takayama K. Effect of temperature-increase rate on drug release characteristics of dextran microspheres prepared by emulsion solvent evaporation process. Int. J. Pharm. 324(2), 144-151 (2006).
44. Bodmeier R, McGinity JW. The preparation and evaluation of drug-containing poly(d,l-lactide) microspheres formed by the solvent evaporation method. Pharm. Res. 4(6), 465-471 (1987).
45. Yushu H, Venkatraman S. The effect of process variables on the morphology and release characteristics of protein-loaded PLGA particles. J. Appl. Polym. Sci. 101(5), 3053-3061 (2006).
46. Yadav VR, Prasad S, Kannappan R et al. Cyclodextrin-complexed curcumin exhibits anti-inflammatory and antiproliferative activities superior to those of curcumin through higher cellular uptake. Biochem. Pharmacol. 80(7), 1021-1032 (2010).
47. Arnida, Malugin A, Ghandehari H. Cellular uptake and toxicity of gold nanoparticles in prostate cancer cells: a comparative study of rods and spheres. J. Appl. Toxicol. 30(3), 212-217 (2010).
48. Chen L, Mccrate JM, Lee JC, Li H. The role of surface charge on the uptake and biocompatibility of hydroxyapatite nanoparticles with osteoblast cells. Nanotechnology 22(10), 105708 (2011).
49. Gratton SE, Ropp PA, Pohlhaus PD et al. The effect of particle design on cellular internalization pathways. Proc. Natl Acad. Sci. USA 105(33), 11613-11618 (2008).